+

WO1998033808A3 - Procede stoechiometrique reversible servant a la conjugaison de biomolecules - Google Patents

Procede stoechiometrique reversible servant a la conjugaison de biomolecules Download PDF

Info

Publication number
WO1998033808A3
WO1998033808A3 PCT/US1998/002007 US9802007W WO9833808A3 WO 1998033808 A3 WO1998033808 A3 WO 1998033808A3 US 9802007 W US9802007 W US 9802007W WO 9833808 A3 WO9833808 A3 WO 9833808A3
Authority
WO
WIPO (PCT)
Prior art keywords
reversible
stoichiometric process
conjugating biomolecules
conjugating
biomolecules
Prior art date
Application number
PCT/US1998/002007
Other languages
English (en)
Other versions
WO1998033808A2 (fr
Inventor
Hubert Koster
Original Assignee
Hubert Koster
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hubert Koster filed Critical Hubert Koster
Priority to EP98906096A priority Critical patent/EP1000081A2/fr
Priority to DE19882066T priority patent/DE19882066T1/de
Priority to JP53319598A priority patent/JP2001526776A/ja
Priority to AU61416/98A priority patent/AU748806B2/en
Priority to CA002284463A priority patent/CA2284463A1/fr
Publication of WO1998033808A2 publication Critical patent/WO1998033808A2/fr
Publication of WO1998033808A3 publication Critical patent/WO1998033808A3/fr
Priority to NO993746A priority patent/NO993746L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)

Abstract

L'invention concerne des compositions renfermant au moins deux biopolymères (p. ex. des acides nucléiques ou des polypeptides), qui sont conjugués à un support insoluble par deux liaisons réversibles différentes, ces liaisons pouvant être coupées dans des conditions sélectives. L'invention concerne également des procédés et des composants destinés à la production de ces compositions.
PCT/US1998/002007 1997-02-04 1998-02-04 Procede stoechiometrique reversible servant a la conjugaison de biomolecules WO1998033808A2 (fr)

Priority Applications (6)

Application Number Priority Date Filing Date Title
EP98906096A EP1000081A2 (fr) 1997-02-04 1998-02-04 Procede stoechiometrique reversible servant a la conjugaison de biomolecules
DE19882066T DE19882066T1 (de) 1997-02-04 1998-02-04 Reversibles stöchiometrisches Verfahren zum Konjugieren von Biomolekülen
JP53319598A JP2001526776A (ja) 1997-02-04 1998-02-04 生体分子を結合するための可逆性化学量論的工程
AU61416/98A AU748806B2 (en) 1997-02-04 1998-02-04 A reversible stoichiometric process for conjugating biomolecules
CA002284463A CA2284463A1 (fr) 1997-02-04 1998-02-04 Procede stoechiometrique reversible servant a la conjugaison de biomolecules
NO993746A NO993746L (no) 1997-02-04 1999-08-03 En reversibel, stökiometrisk prosess for konjugering av biomolekyler

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3716597P 1997-02-04 1997-02-04
US60/037,165 1997-02-04

Publications (2)

Publication Number Publication Date
WO1998033808A2 WO1998033808A2 (fr) 1998-08-06
WO1998033808A3 true WO1998033808A3 (fr) 1999-02-25

Family

ID=21892797

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/002007 WO1998033808A2 (fr) 1997-02-04 1998-02-04 Procede stoechiometrique reversible servant a la conjugaison de biomolecules

Country Status (7)

Country Link
EP (1) EP1000081A2 (fr)
JP (1) JP2001526776A (fr)
AU (1) AU748806B2 (fr)
CA (1) CA2284463A1 (fr)
DE (1) DE19882066T1 (fr)
NO (1) NO993746L (fr)
WO (1) WO1998033808A2 (fr)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6949633B1 (en) 1995-05-22 2005-09-27 Sequenom, Inc. Primers useful for sizing nucleic acids
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
US7074563B2 (en) 1995-03-17 2006-07-11 Sequenom, Inc. Mass spectrometric methods for detecting mutations in a target nucleic acid
US7132519B2 (en) 1996-12-10 2006-11-07 Sequenom, Inc. Releasable nonvolatile mass-label molecules
US7198893B1 (en) 1996-11-06 2007-04-03 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US7332275B2 (en) 1999-10-13 2008-02-19 Sequenom, Inc. Methods for detecting methylated nucleotides
US7432342B2 (en) 2002-05-03 2008-10-07 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof and related documents
US7608394B2 (en) 2004-03-26 2009-10-27 Sequenom, Inc. Methods and compositions for phenotype identification based on nucleic acid methylation
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9034798B2 (en) 2003-01-16 2015-05-19 Caprotec Bioanalytics Gmbh Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity
US9249456B2 (en) 2004-03-26 2016-02-02 Agena Bioscience, Inc. Base specific cleavage of methylation-specific amplification products in combination with mass analysis
US9394565B2 (en) 2003-09-05 2016-07-19 Agena Bioscience, Inc. Allele-specific sequence variation analysis

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6225061B1 (en) 1999-03-10 2001-05-01 Sequenom, Inc. Systems and methods for performing reactions in an unsealed environment
US20020009394A1 (en) 1999-04-02 2002-01-24 Hubert Koster Automated process line
US7917301B1 (en) 2000-09-19 2011-03-29 Sequenom, Inc. Method and device for identifying a biological sample
US20020155587A1 (en) 2001-04-20 2002-10-24 Sequenom, Inc. System and method for testing a biological sample
JP3935487B2 (ja) * 2001-07-16 2007-06-20 フーベルト・ケスター 捕獲化合物、その収集物、ならびにプロテオームおよび複合組成物の分析方法
WO2019081680A1 (fr) * 2017-10-25 2019-05-02 Institut Pasteur Immobilisation d'acides nucléiques à l'aide d'un mimétique d'étiquette histidine enzymatique pour des applications de diagnostic

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004674A1 (fr) * 1984-04-05 1985-10-24 Life Technologies, Inc. Immobilisation d'acides nucleiques
DE3644346A1 (de) * 1986-12-19 1987-05-21 Saeulentechnik Dr Ing Herbert Matrixgebundene kronenetherliganden als trennmaterial in der affinitaetschromatographie von nukleinsaeuren
WO1989005616A1 (fr) * 1987-12-24 1989-06-29 Bio-Metric Systems, Inc. Revetements biocompatibles
WO1990001564A1 (fr) * 1988-08-09 1990-02-22 Microprobe Corporation Procedes d'analyse a cibles multiples par hybridation d'acides nucleiques
US5410068A (en) * 1989-10-23 1995-04-25 Perseptive Biosystems, Inc. Succinimidyl trityl compounds and a process for preparing same
US5547835A (en) * 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
WO1998020020A2 (fr) * 1996-11-06 1998-05-14 Sequenom, Inc. Immobilisation haute densite d'acides nucleiques

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985004674A1 (fr) * 1984-04-05 1985-10-24 Life Technologies, Inc. Immobilisation d'acides nucleiques
DE3644346A1 (de) * 1986-12-19 1987-05-21 Saeulentechnik Dr Ing Herbert Matrixgebundene kronenetherliganden als trennmaterial in der affinitaetschromatographie von nukleinsaeuren
WO1989005616A1 (fr) * 1987-12-24 1989-06-29 Bio-Metric Systems, Inc. Revetements biocompatibles
WO1990001564A1 (fr) * 1988-08-09 1990-02-22 Microprobe Corporation Procedes d'analyse a cibles multiples par hybridation d'acides nucleiques
US5410068A (en) * 1989-10-23 1995-04-25 Perseptive Biosystems, Inc. Succinimidyl trityl compounds and a process for preparing same
US5582981A (en) * 1991-08-14 1996-12-10 Gilead Sciences, Inc. Method for identifying an oligonucleotide aptamer specific for a target
US5547835A (en) * 1993-01-07 1996-08-20 Sequenom, Inc. DNA sequencing by mass spectrometry
WO1998020020A2 (fr) * 1996-11-06 1998-05-14 Sequenom, Inc. Immobilisation haute densite d'acides nucleiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
ARSHADY E: "BEADED POLYMER SUPPORTS AND GELS II. PHYSICO-CHEMICAL CRITERIA AND FUNCTIONALIZATION", JOURNAL OF CHROMATOGRAPHY, vol. 586, no. 2, 22 November 1991 (1991-11-22), pages 199 - 219, XP000247969 *
P.D.GERSHON ET AL.: "Stable Chelating Linkage for Reversible Immobilization of Oligohistidine Tagged Proteins in the BIAcore Surface Plasmon Resonance Detector.", JOURNAL OF IMMUNOLOGICAL METHODS, vol. 183, 1995, pages 65 - 76, XP002081778 *
PON R T ET AL: "DERIVATIZATION OF CONTROLLED PORE GLASS BEADS FOR SOLID PHASE OLIGONUCLEOTIDE SYNTHESIS", BIOTECHNIQUES, vol. 6, no. 8, 1 January 1988 (1988-01-01), pages 768 - 770, 773 - 775, XP000562920 *
SCOUTEN W H ET AL: "REVERSIBLE IMMOBILIZATION OF ANTIBODIES ON MAGNETIC BEADS", ANALYTICAL BIOCHEMISTRY, vol. 205, no. 2, 1 September 1992 (1992-09-01), pages 313 - 318, XP000296795 *

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7419787B2 (en) 1995-03-17 2008-09-02 Sequenom, Inc. Mass spectrometric methods for detecting mutations in a target nucleic acid
US7074563B2 (en) 1995-03-17 2006-07-11 Sequenom, Inc. Mass spectrometric methods for detecting mutations in a target nucleic acid
US6949633B1 (en) 1995-05-22 2005-09-27 Sequenom, Inc. Primers useful for sizing nucleic acids
US7501251B2 (en) 1996-11-06 2009-03-10 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US7198893B1 (en) 1996-11-06 2007-04-03 Sequenom, Inc. DNA diagnostics based on mass spectrometry
US7132519B2 (en) 1996-12-10 2006-11-07 Sequenom, Inc. Releasable nonvolatile mass-label molecules
US7332275B2 (en) 1999-10-13 2008-02-19 Sequenom, Inc. Methods for detecting methylated nucleotides
US6958214B2 (en) 2000-07-10 2005-10-25 Sequenom, Inc. Polymorphic kinase anchor proteins and nucleic acids encoding the same
US7432342B2 (en) 2002-05-03 2008-10-07 Sequenom, Inc. Kinase anchor protein muteins, peptides thereof and related documents
US9034798B2 (en) 2003-01-16 2015-05-19 Caprotec Bioanalytics Gmbh Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
US9394565B2 (en) 2003-09-05 2016-07-19 Agena Bioscience, Inc. Allele-specific sequence variation analysis
US7608394B2 (en) 2004-03-26 2009-10-27 Sequenom, Inc. Methods and compositions for phenotype identification based on nucleic acid methylation
US9249456B2 (en) 2004-03-26 2016-02-02 Agena Bioscience, Inc. Base specific cleavage of methylation-specific amplification products in combination with mass analysis
US8975082B2 (en) 2008-05-13 2015-03-10 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9096652B2 (en) 2008-05-13 2015-08-04 University Of Kansas Metal abstraction peptide (MAP) tag and associated methods
US9187735B2 (en) 2012-06-01 2015-11-17 University Of Kansas Metal abstraction peptide with superoxide dismutase activity

Also Published As

Publication number Publication date
CA2284463A1 (fr) 1998-08-06
JP2001526776A (ja) 2001-12-18
NO993746L (no) 1999-10-01
NO993746D0 (no) 1999-08-03
AU748806B2 (en) 2002-06-13
DE19882066T1 (de) 2000-01-05
EP1000081A2 (fr) 2000-05-17
WO1998033808A2 (fr) 1998-08-06
AU6141698A (en) 1998-08-25

Similar Documents

Publication Publication Date Title
WO1998033808A3 (fr) Procede stoechiometrique reversible servant a la conjugaison de biomolecules
WO1999041273A3 (fr) Conjugues d'anp et d'adn et procedes de preparation desdits conjugues
WO1999067291A3 (fr) Modification de proteine specifique a un site par mutagenese
CA2355379A1 (fr) Pousseur de materiau compact universel et methode de fabrication
HK1112007A1 (en) Peptide acceptor ligation methods
NO992167L (no) Preparater og fremgangsmÕter for immobilisering av nukleinsyrer til faste bµrere
WO2005050171A3 (fr) Procedes et compositions se rapportant a des reactifs centraux simples
CA2215933A1 (fr) Preparation de produits de recombinaison immunogenes au moyen d'hydrates de carbone solubles actives par l'intermediaire de reactifs organiques de cyanylation
WO2006127910A3 (fr) Formulations d'erythropoietine glycopegylees
CA2155185A1 (fr) Reactifs par affinite, totalement synthetiques
WO2000046069A3 (fr) Materiau generateur de gaz favorisant l'amorçage et procede correspondant
WO2002080979A3 (fr) Conjugues d'amidon hydroxyalkyle et d'agent actif
AU5773798A (en) Pegylation process
SI1305329T1 (sl) S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-(2-furanilkarboksil)oksi-11beta-hidroksi- 16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo
CA2248006A1 (fr) Segments de liaison actives et leurs procedes de fabrication et de purification
WO2002042418A3 (fr) Acide 3-hydroxypropionique et autres composes organiques
WO2004033651A3 (fr) Erythropoietine: remodelage et glycoconjugaison d'erythropoietine
WO2002062999A3 (fr) Proteines et acides nucleiques codant pour celles-ci
WO1999046402A3 (fr) Substrats d'enzymes fluorescents
WO2002038522A3 (fr) Composition d'amelioration et de fertilisation du sol
WO2004050710A3 (fr) Esters d'acide aldonique, procedes pour les preparer et procedes pour preparer des principes actifs pharmaceutiques couples a des polysaccharides ou a des derives de polysaccharides au niveau de groupes amino libres
WO2005014723A8 (fr) Composes de type cyanine avec bras alkynyle de liaison
AU5729296A (en) Soluble, cleavable substrates of the hepatitis c virus prote ase
WO2003084926A3 (fr) Derives acyles polymeriques d'indoles
EP0911399A3 (fr) HTHBZ47, un clone apparenté à une kringle

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2284463

Country of ref document: CA

Ref document number: 2284463

Country of ref document: CA

Kind code of ref document: A

Ref document number: 1998 533195

Country of ref document: JP

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 1998906096

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 61416/98

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 09355705

Country of ref document: US

RET De translation (de og part 6b)

Ref document number: 19882066

Country of ref document: DE

Date of ref document: 20000105

WWE Wipo information: entry into national phase

Ref document number: 19882066

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 1998906096

Country of ref document: EP

WWG Wipo information: grant in national office

Ref document number: 61416/98

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1998906096

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载